Live Breaking News & Updates on Core one lab

Stay informed with the latest breaking news from Core one lab on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Core one lab and stay connected to the pulse of your community

Core One Labs Inc.: Core One Labs' Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer's and Parkinson's, Showing Potential to Outperform Current Treatment Methods

Core One Labs Inc.: Core One Labs' Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer's and Parkinson's, Showing Potential to Outperform Current Treatment Methods
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Canada , Vancouver , British-columbia , Canadian , Stefan-klotter , Akome-bio , Joel-shacker , Health-canada , Vocan-biotechnologies-inc , Canadian-securities-exchange , Core-one-labs-inc , Akome-biotechnologies-inc

Core One Labs' Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer's and Parkinson's, Showing Potential to Outperform Current Treatment Methods

Core One Labs' Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer's and Parkinson's, Showing Potential to Outperform Current Treatment Methods
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

Vancouver , British-columbia , Canada , Canadian , Akome-bio , Joel-shacker , Core-one-labs-inc , Health-canada , Vocan-biotechnologies-inc , Canadian-securities-exchange , Core-one-lab , Akome-biotech-ltd

Core One Labs', Awakened Biosciences, Announces Groundbreaking Step ...

Core One Labs', Awakened Biosciences, Announces Groundbreaking Step ...
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

Vancouver , British-columbia , Canada , United-states , Oregon , America , Canadian , Joel-shacker , Tony-durst , Trademark-office , News-network , Biosciences-inc

Core One Labs', Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin from Mushroom Biomass

Core One Labs', Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin from Mushroom Biomass
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

United-states , Vancouver , British-columbia , Canada , Oregon , Canadian , America , Tony-durst , Joel-shacker , Vocan-biotechnologies-inc , Company-or-core , Biosciences-inc

Core One Labs Inc.: Core One Labs', Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin from Mushroom Biomass

Core One Labs Inc.: Core One Labs', Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin from Mushroom Biomass
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Canada , Vancouver , British-columbia , Oregon , United-states , America , Canadian , Tony-durst , Joel-shacker , Core-one-lab , Core-one-labs-inc-view , Canadian-securities-exchange

Core One Labs Inc.: Core One Labs' Scientists Successfully Complete Breakthrough First Step in Producing API-Grade DMT

Second Ground Breaking Technological AdvancementVANCOUVER, BC / ACCESSWIRE / September 2, 2022 / Core One Labs Inc. (CSE:COOL), (OTCQB:CLABF), (Frankfurt:LD6)(WKN:A3CSSU) (the "Company" or "Core One")

United-states , Canada , Vancouver , British-columbia , American , Canadian , Tony-durst , Joel-shacker , Core-one-lab , Biosciences-inc , Core-one-labs-inc , Akome-biotech-ltd

Core One Labs Highlights Key Points from International Investor Call


Press release content from Accesswire. The AP news staff was not involved in its creation.
Core One Labs Highlights Key Points from International Investor Call
February 11, 2021 GMT
VANCOUVER, BC / ACCESSWIRE / February 10, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (“Core One” the “Company”) is pleased with the tremendous turnout on the International Investors’ Call held earlier today. Core One’s Chairman, Dr. Robert E.W. Hancock and Chief Executive Officer, Joel Shacker provided participants an update on the Company’s current Intellectual Property and patent application process, cost to produce psilocybin, and the commercial viability.

United-states , Canada , Vancouver , British-columbia , Canadian , Robertew-hancock , Joel-shacker , Core-one-lab , Core-one-the-company , International-investor-call , Trademark-office , Core-one-labs-inc

Core One Labs Inc.: Core One Labs Highlights Key Points from International Investor Call


Core One Labs Inc.: Core One Labs Highlights Key Points from International Investor Call
Core One" the "
Company") is pleased with the tremendous turnout on the International Investors' Call held earlier today. Core One's Chairman, Dr. Robert E.W. Hancock and Chief Executive Officer, Joel Shacker provided participants an update on the Company's current Intellectual Property and patent application process, cost to produce psilocybin, and the commercial viability.
Highlights
Intellectual Property and Patent Process
Dr. Hancock announced that the Company has assembled the necessary data for its research and development program on biosynthetic psilocybin production systems in order to commence the process of preparing and filing its first patent application with the United States Patent and Trademark Office. The initial filing is the first in a series of upcoming patent filings aimed at protecting valuable intellectual property that underpins the proprietary fermentative production process for active pharmaceutical ingredient (API) grade psilocybin.

United-states , Canada , Vancouver , British-columbia , Canadian , Robertew-hancock , Joel-shacker , Core-one-lab , Core-one-the-company , International-investor-call , Trademark-office , Core-one-labs-inc